文献速递妇科

绝经后妇女子宫内膜取样诊断为非典型子宫内膜增生后的长期结局

Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-02-28

这项回顾性研究纳入1997至2008年在学术医疗中心接受子宫内膜取样的55岁及以上妇女,比较当前或近期诊断为非典型子宫内膜增生(NEH)者与萎缩性子宫内膜(AE)者的长期结局,随访至2018年2月。NEH组进展为1型子宫内膜癌、持续NEH及接受后续手术的比例均显著高于AE组。多变量分析中仅NEH为进展为子宫内膜癌或EH持续的显著危险因素。

要点

  • NEH组进展为1型子宫内膜癌8.3%,AE组0.8%(P=0.0003)。
  • NEH组持续NEH 22.2%,AE组0.7%(P<0.0001)。
  • NEH组后续子宫切除34.7%,AE组9.8%(P<0.0001)。

核心结论

  • 绝经后NEH妇女持续EH和进展为子宫内膜癌的风险显著,且高于既往报道的发生率。
  • 作者认为需要针对绝经后NEH妇女适当管理的指南,以降低持续病变或进展为癌的发生率。

研究设计与样本

  • 回顾性研究,纳入1997至2008年在学术医疗中心接受子宫内膜取样、年龄55岁及以上的妇女。
  • 研究组为当前或近期(<2年)组织学诊断为NEH的妇女,对照组为诊断为萎缩性子宫内膜(AE)的妇女,结局数据获取至2018年2月。
  • 研究期间共1808名55岁及以上妇女接受子宫内膜取样,NEH组72例,AE组722例,中位监测时间10.0年。

主要发现

  • 与AE组相比,NEH组体重指数更高(33.9 kg/m2 vs 30.6 kg/m2;P=0.01),子宫内膜更厚(10.00 mm vs 6.00 mm;P=0.01)。
  • NEH组进展为1型子宫内膜癌的比例高于AE组(8.3% vs 0.8%;P=0.0003),持续NEH比例亦高于AE组(22.2% vs 0.7%;P<0.0001)。
  • NEH组进展为任何类型子宫癌或持续EH的比例高于AE组(33.3% vs 3.5%;P<0.0001)。
  • NEH组后续接受手术干预的比例高于AE组(51.4% vs 15.8%;P<0.0001),其中后续子宫切除比例亦高于AE组(34.7% vs 9.8%;P<0.0001)。
  • 多变量logistic回归分析中,仅NEH为进展为子宫内膜癌或EH持续的显著危险因素。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the long-term outcome of postmenopausal women diagnosed with non-atypical endometrial hyperplasia (NEH). METHODS: This was a retrospective study of women aged 55 or older who underwent endometrial sampling in our academic medical center between 1997 and 2008. Women who had a current or recent (< 2 years) histological diagnosis of NEH were included in the study group and were compared with those diagnosed with atrophic endometrium (AE). Outcome data were obtained until February 2018. The main outcomes were risk of progression to endometrial carcinoma and risk of persistence, recurrence or new development of endometrial hyperplasia (EH) ('persistent EH'). Logistic regression analysis was used to identify covariates that were independent risk factors for progression to endometrial cancer or persistent EH. RESULTS: During the study period, 1808 women aged 55 or older underwent endometrial sampling. The median surveillance time was 10.0 years. Seventy-two women were found to have a current or recent diagnosis of NEH and were compared with 722 women with AE. When compared to women with AE, women with NEH had significantly higher body mass index (33.9 kg/m2 vs 30.6 kg/m2 ; P = 0.01), greater endometrial thickness (10.00 mm vs 6.00 mm; P = 0.01) and higher rates of progression to type-1 endometrial cancer (8.3% vs 0.8%; P = 0.0003) and persistent NEH (22.2% vs 0.7%; P < 0.0001). They also had a higher rate of progression to any type of uterine cancer or persistent EH (33.3% vs 3.5%; P < 0.0001). Women with NEH had a significantly higher rate of future surgical intervention (51.4% vs 15.8%; P < 0.0001), including future hysterectomy (34.7% vs 9.8%; P < 0.0001). On multivariable logistic regression analysis, only NEH remained a significant risk factor for progression to endometrial cancer or persistence of EH. CONCLUSIONS: Postmenopausal women with NEH are at significant risk for persistent EH and progression to endometrial cancer, at rates higher than those reported previously. Guidelines for the appropriate management of postmenopausal women with NEH are needed in order to decrease the rate of persistent disease or progression to cancer. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rotenberg O, Fridman D, Doulaveris G, et al. Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling. Ultrasound Obstet Gynecol. 2020. PMID: 31389091. doi:10.1002/uog.20421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。